Ignite Creation Date:
2024-05-05 @ 11:37 AM
Last Modification Date:
2024-10-26 @ 9:11 AM
Study NCT ID:
NCT00099619
Status:
COMPLETED
Last Update Posted:
2015-02-23
First Post:
2004-12-17
Brief Title:
Comparing Exenatide and Insulin Glargine in Type 2 Diabetes Patients for Whom Insulin is the Next Appropriate Therapy
Sponsor:
AstraZeneca
Organization:
AstraZeneca